Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FeRx and Elan to develop MTC-DOX for treatment of liver cancer

Nov. 30, 2000

Deltagen obtains license to develop potential AML treatment

Nov. 30, 2000

Enhanced expression of p21 associated with responses to rAd-p53 gene therapy in NSCLC

Nov. 29, 2000

PK-11195 is able to sensitize cholangiocarcinoma cells to radiation-induced apoptosis

Nov. 29, 2000

Favorable pharmacokinetic and tolerability profile for Angiozyme in humans

Nov. 29, 2000

Antitumor agents from Spanish university induce apoptosis

Nov. 28, 2000

Oncologic Drugs Advisory Committee meeting in mid-December has a full agenda

Nov. 28, 2000

CI-1042 shows biological activity in refractory head and neck cancer

Nov. 28, 2000

Servier compares in vitro/in vivo antitumor activity of new olivacines to doxorubicin and VP-16

Nov. 27, 2000

MGI Pharma and MethylGene begin phase II evaluation of MG-98 in head and neck cancer

Nov. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...